4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1)

4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) Basic information
Product Name:4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1)
Synonyms:4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1);TLR7/8 agonist 4 hydroxy-PEG10-acid hydrochloride
CAS:2388520-36-1
MF:C41H69ClN6O12
MW:873.48
EINECS:
Product Categories:
Mol File:2388520-36-1.mol
4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) Structure
4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) Chemical Properties
Safety Information
MSDS Information
4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) Usage And Synthesis
4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) Preparation Products And Raw materials
Tag:4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1)(2388520-36-1) Related Product Information